Ovatodiolide alone or in combination with Imatinib induce apoptotic cell death in CD34+CD38− CML cells by dysregulating the PI3K/AKT/mTOR pathway. The gene discussed is CD38; the disease is chronic myelogenous leukemia, BCR-ABL1 positive.